Nova Eye Medical Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Tom Spurling

Chief executive officer

AU$291.1k

Total compensation

CEO salary percentage84.3%
CEO tenure4.3yrs
CEO ownership0.4%
Management average tenure6.2yrs
Board average tenure6.3yrs

Recent management updates

Recent updates

We Think Nova Eye Medical (ASX:EYE) Can Afford To Drive Business Growth

Nov 04
We Think Nova Eye Medical (ASX:EYE) Can Afford To Drive Business Growth

Nova Eye Medical Limited (ASX:EYE) Might Not Be As Mispriced As It Looks After Plunging 26%

Sep 22
Nova Eye Medical Limited (ASX:EYE) Might Not Be As Mispriced As It Looks After Plunging 26%

Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Aug 06
Take Care Before Diving Into The Deep End On Nova Eye Medical Limited (ASX:EYE)

Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Apr 18
Nova Eye Medical Limited (ASX:EYE) Soars 29% But It's A Story Of Risk Vs Reward

Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

Mar 26
Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 43% Undervaluation?

News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Jan 19
News Flash: Analysts Just Made A Captivating Upgrade To Their Nova Eye Medical Limited (ASX:EYE) Forecasts

Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

Dec 27
Further Upside For Nova Eye Medical Limited (ASX:EYE) Shares Could Introduce Price Risks After 38% Bounce

We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Sep 03
We're Not Very Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Rate

Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Apr 17
Improved Revenues Required Before Nova Eye Medical Limited (ASX:EYE) Stock's 43% Jump Looks Justified

Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

Dec 16
Is Nova Eye Medical (ASX:EYE) In A Good Position To Invest In Growth?

We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

Aug 27
We Think Nova Eye Medical (ASX:EYE) Needs To Drive Business Growth Carefully

CEO Compensation Analysis

How has Tom Spurling's remuneration changed compared to Nova Eye Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$291kAU$245k

-AU$9m

Mar 31 2024n/an/a

-AU$12m

Dec 31 2023n/an/a

-AU$14m

Sep 30 2023n/an/a

-AU$15m

Jun 30 2023AU$253kAU$211k

-AU$15m

Mar 31 2023n/an/a

-AU$13m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$9m

Jun 30 2022AU$311kAU$191k

-AU$7m

Mar 31 2022n/an/a

-AU$7m

Dec 31 2021n/an/a

-AU$6m

Sep 30 2021n/an/a

-AU$5m

Jun 30 2021AU$72kAU$66k

-AU$4m

Dec 31 2020n/an/a

-AU$9m

Sep 30 2020n/an/a

-AU$10m

Jun 30 2020n/an/a

-AU$10m

Dec 31 2019n/an/a

-AU$6m

Sep 30 2019n/an/a

-AU$6m

Jun 30 2019AU$328kAU$306k

-AU$7m

Mar 31 2019n/an/a

-AU$7m

Dec 31 2018n/an/a

-AU$6m

Sep 30 2018n/an/a

-AU$6m

Jun 30 2018AU$329kAU$300k

-AU$5m

Compensation vs Market: Tom's total compensation ($USD189.18K) is below average for companies of similar size in the Australian market ($USD297.98K).

Compensation vs Earnings: Tom's compensation has increased whilst the company is unprofitable.


CEO

Tom Spurling (62 yo)

4.3yrs

Tenure

AU$291,117

Compensation

Mr. Thomas H. Spurling, also known as Tom, BSc (Hons), Ph D., FRACI, FTSE, AM is an Executive Director at Nova Eye Medical Limited since August 31, 2020 and serves as its Managing Director. Mr. Spurling wa...


Leadership Team

NamePositionTenureCompensationOwnership
Victor Previn
Founder & Executive Chairman23.3yrsAU$254.51kno data
Thomas Spurling
MD & Executive Directorno dataAU$291.12k0.37%
A$ 126.8k
Kimberley Menzies
Chief Financial Officerno datano datano data
Mark Flynn
Investor Relationsno datano datano data
Kate Hunt
Chief Commercial Officerno datano datano data
David Lubeck
Chief Medical Officer6.1yrsno datano data
Joaquin Wolff
President of Ellex iTrack6.3yrsno datano data
Simon Jeremy Gray
Company Secretary4.4yrsno datano data
Don Watton
Vice President of Global Serviceno dataAU$143.97kno data
Meera Verma
Advisor to the Boardno dataAU$243.97kno data

6.2yrs

Average Tenure

66yo

Average Age

Experienced Management: EYE's management team is seasoned and experienced (6.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Victor Previn
Founder & Executive Chairman23.3yrsAU$254.51kno data
Thomas Spurling
MD & Executive Director4.3yrsAU$291.12k0.37%
A$ 126.8k
Rahmon Coupe
Independent Director11.5yrsAU$55.50k0.59%
A$ 201.2k
Michael Southard
Non Executive Director6.3yrsAU$61.05k0.0087%
A$ 3.0k
Daniel Webb
Independent Director2yrsAU$61.05k0.24%
A$ 83.3k

6.3yrs

Average Tenure

62yo

Average Age

Experienced Board: EYE's board of directors are considered experienced (6.3 years average tenure).